Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenia Nicolov

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Drug Targets|February 24, 2015
Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery SystemSilvia Ferrati, Eugenia Nicolov, Shyam Bansal, et al.
Cells, Tissues, Organs|September 25, 2013
Culture of mouse amniotic fluid-derived cells on irradiated STO feeders results in the generation of primitive endoderm cell lines capable of self-renewal in vitroAleksandar M Babic, Sunyoung Jang, Eugenia Nicolov, et al.
Materials (Basel, Switzerland)|June 14, 2016
Sustained Administration of Hormones Exploiting Nanoconfined Diffusion through Nanochannel MembranesThomas Geninatti, R Lyle Hood, Giacomo Bruno, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 6, 2017
A pharmacokinetic study of GC-1 delivery using a nanochannel membrane deviceCarly S Filgueira, Andrea Ballerini, Eugenia Nicolov, et al.
The Journal of Sexual Medicine|May 2, 2015
The nanochannel delivery system for constant testosterone replacement therapySilvia Ferrati, Eugenia Nicolov, Erika Zabre, et al.
Advanced Healthcare Materials|October 3, 2014
Delivering enhanced testosterone replacement therapy through nanochannelsSilvia Ferrati, Eugenia Nicolov, Shyam Bansal, et al.
Analytical and Bioanalytical Chemistry|October 24, 2012
Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart healthJuliana Sih, Shyam S Bansal, Stefano Filippini, et al.
Biotechnology Journal|July 23, 2017
3D Printed Vascularized Device for Subcutaneous Transplantation of Human IsletsMarco Farina, Andrea Ballerini, Daniel W Fraga, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Drug Targets|February 24, 2015
Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery SystemSilvia Ferrati, Eugenia Nicolov, Shyam Bansal, et al.
Cells, Tissues, Organs|September 25, 2013
Culture of mouse amniotic fluid-derived cells on irradiated STO feeders results in the generation of primitive endoderm cell lines capable of self-renewal in vitroAleksandar M Babic, Sunyoung Jang, Eugenia Nicolov, et al.
Materials (Basel, Switzerland)|June 14, 2016
Sustained Administration of Hormones Exploiting Nanoconfined Diffusion through Nanochannel MembranesThomas Geninatti, R Lyle Hood, Giacomo Bruno, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 6, 2017
A pharmacokinetic study of GC-1 delivery using a nanochannel membrane deviceCarly S Filgueira, Andrea Ballerini, Eugenia Nicolov, et al.
The Journal of Sexual Medicine|May 2, 2015
The nanochannel delivery system for constant testosterone replacement therapySilvia Ferrati, Eugenia Nicolov, Erika Zabre, et al.
Advanced Healthcare Materials|October 3, 2014
Delivering enhanced testosterone replacement therapy through nanochannelsSilvia Ferrati, Eugenia Nicolov, Shyam Bansal, et al.
Analytical and Bioanalytical Chemistry|October 24, 2012
Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart healthJuliana Sih, Shyam S Bansal, Stefano Filippini, et al.
Biotechnology Journal|July 23, 2017
3D Printed Vascularized Device for Subcutaneous Transplantation of Human IsletsMarco Farina, Andrea Ballerini, Daniel W Fraga, et al.
Pageof 1